• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Defective sulfation factor generation: a possible etiological link in dwarfism.

作者信息

Daughaday W H, Laron Z, Pertzelan A, Heins J N

出版信息

Trans Assoc Am Physicians. 1969;82:129-40.

PMID:5375147
Abstract
摘要

相似文献

1
Defective sulfation factor generation: a possible etiological link in dwarfism.硫酸化因子生成缺陷：侏儒症可能的病因联系。
Trans Assoc Am Physicians. 1969;82:129-40.
2
Pseudohypopituitary dwarfism with normal plasma growth hormone and low serum sulfation factor.血浆生长激素正常但血清硫酸化因子水平低的假性垂体性侏儒症
J Pediatr. 1972 Apr;80(4):620-6. doi: 10.1016/s0022-3476(72)80059-3.
3
Genetic aspects of pituitary dwarfism due to absence or biological inactivity of growth hormone.
Isr J Med Sci. 1968 Jul-Aug;4(4):895-900.
4
[Nanism with high values of GH and no generation of somatomedin after hGH (Laron's syndrome). Clinico-biochemical study of 8 cases].[生长激素水平高但生长激素释放激素（hGH）后未产生生长调节素的侏儒症（拉伦综合征）。8例临床生化研究]
An Esp Pediatr. 1985 Feb;22(2):113-22.
5
[Severe dwarfism with high plasma hGH levels and no somatomedin acitvity: Laron's syndrome (author's transl)].严重侏儒症伴高血浆人生长激素水平且无生长调节素活性：拉龙综合征（作者译）
Sem Hop. 1980;56(43-44):1853-6.
6
[Growth and growth hormone. On the differential diagnosis and therapy of proportioned (pituitary) dwarfism].
Munch Med Wochenschr. 1968 Aug 4;110(51):2965-70.
7
[Familial hypophyseal dwarfism].
Schweiz Med Wochenschr. 1968 May 11;98(19):705-9.
8
Genetic dwarfism with high growth hormone levels--multiple causation of GH nonresponsiveness.生长激素水平高的遗传性侏儒症——生长激素无反应性的多种病因
Isr J Med Sci. 1993 Dec;29(12):800-1.
9
Administration of growth hormone to patients with familial dwarfism with high plasma immunoreactive growth hormone: measurement of sulfation factor, metabolic and linear growth responses.给血浆免疫反应性生长激素水平高的家族性侏儒症患者使用生长激素：硫酸化因子的测量、代谢及线性生长反应
J Clin Endocrinol Metab. 1971 Aug;33(2):332-42. doi: 10.1210/jcem-33-2-332.
10
[Behavior of somatotropinemia and insulinemia in some forms of short stature].[某些形式身材矮小症中生长激素血症和胰岛素血症的表现]
Folia Endocrinol. 1969 Dec;22(4):373-91.

引用本文的文献

1
Disabilities and Handicaps of Patients with Laron Syndrome.拉龙综合征患者的残疾与障碍
Children (Basel). 2025 Sep 22;12(9):1271. doi: 10.3390/children12091271.
2
Laron syndrome - A historical perspective.拉隆综合征——历史视角。
Rev Endocr Metab Disord. 2021 Mar;22(1):31-41. doi: 10.1007/s11154-020-09595-0. Epub 2020 Sep 22.
3
Physiology and disorders of the growth hormone receptor (GHR) and GH-GHR signal transduction.生长激素受体（GHR）的生理学与疾病以及GH-GHR信号转导
Endocrine. 2000 Apr;12(2):107-19. doi: 10.1385/ENDO:12:2:107.
4
Familial growth hormone insensitivity syndrome.家族性生长激素不敏感综合征
Indian J Pediatr. 1995 Mar-Apr;62(2):244-7. doi: 10.1007/BF02752337.
5
Familial growth hormone insensitivity syndrome.家族性生长激素不敏感综合征
Indian J Pediatr. 1995 Jan-Feb;62(1):123-5. doi: 10.1007/BF02752197.
6
Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications.脑儿茶酚胺和乙酰胆碱在生长激素分泌过多状态中的作用。病理生理学、诊断及治疗意义。
Drugs. 1995 Nov;50(5):805-37. doi: 10.2165/00003495-199550050-00004.
7
Familial dwarfism with high IR-GH: report of two affected sibs with genetic and epidemiologic considerations.伴有高胰岛素抵抗性生长激素的家族性侏儒症：两例患病同胞的报告及遗传和流行病学考量
Hum Genet. 1981;59(4):367-72. doi: 10.1007/BF00295474.
8
Human fetal cartilage response to plasma somatomedin activity in relation to gestational age.人类胎儿软骨对血浆生长调节素活性的反应与胎龄的关系。
Calcif Tissue Int. 1981;33(3):205-9. doi: 10.1007/BF02409439.
9
Pseudopituitary dwarfism due to resistance to somatomedin: a new syndrome.
Eur J Pediatr. 1984 Aug;142(3):186-8. doi: 10.1007/BF00442446.
10
Short stature and its treatment.身材矮小及其治疗。
Br Med J. 1972 May 27;2(5812):519-22. doi: 10.1136/bmj.2.5812.519.